---
title: "SIFANG NEW MATERIAL: Net profit loss of 26.3261 million yuan in the first half of 2025"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/255190217.md"
description: "SIFANG NEW MATERIAL announced that its operating revenue in the first half of 2025 was 540 million yuan, a year-on-year decrease of 22.59%. The net profit loss was 26.3261 million yuan, compared to a net profit of 11.3046 million yuan in the same period last year"
datetime: "2025-08-29T11:29:10.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/255190217.md)
  - [en](https://longbridge.com/en/news/255190217.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/255190217.md)
---

# SIFANG NEW MATERIAL: Net profit loss of 26.3261 million yuan in the first half of 2025

SIFANG NEW MATERIAL announced that its operating revenue in the first half of 2025 was 540 million yuan, a year-on-year decrease of 22.59%. The net profit loss was 26.3261 million yuan, compared to a net profit of 11.3046 million yuan in the same period last year

### Related Stocks

- [605122.CN](https://longbridge.com/en/quote/605122.CN.md)

## Related News & Research

- [Cocoa Prices Sink as the Global Supply Outlook Improves](https://longbridge.com/en/news/286797386.md)
- [Harbor Freight sells metal detectors, but are they any good? Here's what users say](https://longbridge.com/en/news/286790968.md)
- [CMOC Group (CMCLF): New Buy Recommendation for This Basic Materials Giant](https://longbridge.com/en/news/286625840.md)
- [PTA-DD: Warimpex Finanz- und Beteiligungs AG: Correction of a Managers' transactions announcement according to article 19 MAR from 19.05.2026](https://longbridge.com/en/news/287058272.md)
- [China's Bio-Thera Gets US Nod for Golimumab Biosimilar](https://longbridge.com/en/news/286880573.md)